The properties relevant to pharmacokinetics and pharmacodynamics of four series of synthesized s-triazine derivatives have been studied by Quantitative structure-retention relationship (QSRR) approach. The chromatographic behavior of these compounds was investigated by using reversed-phase high performance thin-layer chromatography (RP-HPTLC). Chromatographic retention (RM0) was correlated with...

OBJECTIVE To evaluate the single dose pharmacokinetics of an intravenous dose of lorazepam in pediatric patients treated for status epilepticus (SE) or with a history of SE. STUDY DESIGN Ten hospitals in the Pediatric Emergency Care Applied Research Network enlisted patients 3 months to 17 years with convulsive SE (status cohort) or for a traditional pharmacokinetics study (elective cohort). ...

this study was done to assess bioequivalence between test and reference formulations of escitalopram oxalate 20 mg in healthy indian male subjects. this single-dose, randomized, open-label, 2-period crossover study was carried out in 12 healthy indian male volunteers aged 18 to 55 years under fasting conditions with a wash out of 14 days.  the subjects were randomly assigned to receive the test...

there is no randomized study carried out in order to compare their pharmacokinetic parameters although midazolam, as a sedative, has been widely administered via continuous infusion as well as intermittent bolus doses in mechanically ventilated critically ill patients. we prospectively investigated the effect of these two principal methods on pharmacokinetic parameters in 23 of mentioned patien...

conclusions these data suggest that am404’s concentration-time profile in the brain is similar to those of acetaminophen and its other metabolites. measurement of blood acetaminophen concentration seems to reflect the concentration of the prospective bioactive substance, am404. results the maximum plasma concentrations of acetaminophen and am404 in the rat brain were 15.8 µg/g and 150 pg/g, res...

Disulfiram was the first pharmacotherapy approved to treat alcohol use disorder in the 1950s. Disulfiram alters ethanol pharmacokinetics and causes uncomfortable reactions (e.g. headache, tachycardia, nausea, flushing and hypotension) when alcohol is consumed. Subsequently, a better understanding of the neurobiological pathways involved in alcohol use disorder led to the development of other me...

P-glycoprotein (P-gp) is an ATP-dependent efflux membrane transporter involved in many drug pharmacokinetics in humans. Decreasing its expression could enhance the bioavailability of substrates as digoxin. We have recently found that human recombinant interleukin-2 (rIL2) in vivo decreases P-gp expression in intestine and brain of mice and modifies oral digoxin pharmacokinetics. The aim of the ...

A microfluidic platform that enables formation of biomimetic, asymmetric droplet interface bilayers (DIBs) as cell models for cancer pharmacokinetics.